Association between cognitive representation of illness and the outcome of patients with premature coronary artery disease.


Journal

Journal of psychosomatic research
ISSN: 1879-1360
Titre abrégé: J Psychosom Res
Pays: England
ID NLM: 0376333

Informations de publication

Date de publication:
11 2022
Historique:
received: 19 02 2022
revised: 24 07 2022
accepted: 20 08 2022
pubmed: 11 9 2022
medline: 19 10 2022
entrez: 10 9 2022
Statut: ppublish

Résumé

To assess whether illness perception (IP) in overall and each of its three dimensions (cognitive, emotional and comprehension) have an independent prognostic value in men and women with premature coronary artery disease (CAD). In a prospective cohort, 778 patients (370 men and 408 women) with premature CAD(diagnosed in men aged<45 y and women aged<55 y), who had completed brief illness perception questionnaire were followed up for 4 years. Outcome event was defined as composite of all-cause mortality, nonfatal myocardial infarction(MI), repeated revascularization or/and stroke. Analysis was performed for men and women separately. High scores for each item of illness perception indicate positive perception. Among men, 90 patients (24.3%) experienced events: 14(3.8%) death, 23(6.2%) nonfatal MI, 9(2.4%) strokes, and 44(11.9%) revascularization. Men with and without event showed no difference regarding the traditional risk factors, depression and anxiety symptoms. Among women, 72(17.6%) had events: 11(2.7%) death, 23(5.6%) nonfatal MI, 7(1.7%) strokes and 31(7.6%) revascularization; who had a lower education, more severe CAD, and more depressive symptoms. After adjustments for potential confounders, overall IP and only its cognitive dimension were significantly associated with the outcome in women:1-score increase in the women's cognitive perception resulted in an 18% decrease in the event (HR = 0.82, 95% CI:0.72 to 0.95; P = 0.007). In the men, this effect remained nonsignificant either for IP or its dimensions. Positive cognitive representation of illness was predictive of a decreased likelihood of mortality and/or cardiovascular events in women with premature CAD. Interventional studies are needed to confirm the results.

Identifiants

pubmed: 36087351
pii: S0022-3999(22)00304-X
doi: 10.1016/j.jpsychores.2022.111019
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111019

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests to report.

Auteurs

Masoumeh Lotfi-Tokaldany (M)

Cardiovascular disease research institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Saeed Sadeghian (S)

Cardiovascular disease research institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran; Cardiac electrophysiology department, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Seyed Ali Mosavi (SA)

Interventional cardiology department, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Negar Omidi (N)

Cardiovascular disease research institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran; Cardiac imaging department, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Zahra Rahnemoun (Z)

Echocardiography department, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Elham Hakki Kazzazi (EH)

Psychiatry department, Iran University of Medical Sciences, Tehran, Iran.

Arash Jalali (A)

Cardiovascular disease research institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Nazila Shahmansouri (N)

Cardiovascular disease research institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran; Psychiatry department, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: n.shahmansouri@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH